LEAP THERAPEUTICS, INC.·4

Sep 2, 9:28 PM ET

O'Mahony John Mark 4

4 · LEAP THERAPEUTICS, INC. · Filed Sep 2, 2022

Insider Transaction Report

Form 4
Period: 2022-09-01
O'Mahony John Mark
Chief Manufacturing Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2022-09-01+200,000200,000 total
    Exercise: $1.43Exp: 2032-08-31Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]The Option was granted pursuant to Leap's 2022 Equity Incentive Plan and shall vest and become exercisable in a series of 36 equal monthly installments until the Option is fully vested, with the first such monthly installment vesting on the one month anniversary of September 1, 2022, the Vesting Start Date.

Documents

1 file
  • 4
    tm2225099-10_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT